✦ LIBER ✦

Bioequivalence, pharmacokinetic and pharmacodynamic response to combined extended release formulations of felodipine and metoprolol in healthy volunteers

✍ Scribed by J. Åberg; B. Abrahamsson; M. Grind; G. Nyberg; B. Olofsson

Publisher: Springer
Year: 1997
Tongue: English
Weight: 160 KB
Volume: 52
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s002280050321

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The pharmacokinetics and pharmacodynamic

The pharmacokinetics and pharmacodynamics of metoprolol after conventional and controlled-release administration in combination with hydrochlorothiazide in healthy volunteers

✍ P. Lundborg; B. Abrahamsson; I. Wieselgren; M. Walter 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 302 KB

We have studied a controlled-release formulation containing metoprolol 100 mg and hydrochlorothiazide 12.5 mg. We compared the pharmacokinetics of both substances and the pharmacodynamics of metoprolol with those of a conventional combination tablet. The controlled-release formulation gave less vari

The pharmacodynamic and pharmacokinetic

The pharmacodynamic and pharmacokinetic profiles of controlled-release formulations of felodipine and metoprolol in free and fixed combinations in elderly hypertensive patients

✍ J.S. McLay; T.M. MacDonald; J. Hosie; H.L. Elliott 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 107 KB

Pharmacokinetic and pharmacodynamic char

Pharmacokinetic and pharmacodynamic characteristics of a controlled-release formulation of trazodone versus the conventional formulation in healthy volunteers

✍ P. Monteleone; G. Delrio 📂 Article 📅 1993 🏛 Springer Milan 🌐 English ⚖ 485 KB

Comparative pharmacokinetic profiles of

Comparative pharmacokinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers

✍ J. Godbillon; A. Gerardin; V. A. John; W. Theobald 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 480 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of a slow-release formulation of diltiazem after the administration of a single and repeated doses to healthy volunteers

✍ M. Lefebvre; Y. Lacasse; J. Spénard; D. Geadah; R. Moisan; D. Gossard; H. Landri 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 782 KB

Diltiazem is a calcium antagonist used in angina pectoris and hypertension. There is little information concerning the slow-release (SR) formulation in the literature. The pharmacokinetics of diltiazem SR (120 mg) have been assessed over a 36 h period in healthy volunteers after single-(SD) and mult